GAL1704 for Cheek Augmentation and Correction of Midface Contour Deficiencies

Completed · Not applicable

Conditions studied: Cheek Augmentation

In brief

An interventional study to evaluate the safety and effectiveness of GAL1704 for cheek augmentation and the correction of midface volume deficiencies by demonstrating non-inferiority in change from baseline, relative to an active comparator.

Key facts

Study ID: NCT03700047
Run by: Galderma R&D
People needed: 270
Starts: 2018-10-18
Expected to finish: 2020-05-22
Last updated by the study team: 2022-08-26

Who can join

Age: 22 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

Subjects assessed at baseline by the Blinded Evaluator as Grade 2, 3, or 4 on the MMVS on each side of the midface.

You may not qualify if…

Previous use of any HA based or collagen based biodegradable tissue augmentation therapy within 12 months prior to the baseline visit

Where it is running

Galderma Study site — Los Angeles, California, United States
Galderma Study Site — Sacramento, California, United States
Galderma Study Site — Solana Beach, California, United States
Galderma Study Site — Miami, Florida, United States
Galderma Study Site — West Palm Beach, Florida, United States
Galderma Study Site — New Orleans, Louisiana, United States
Galderma Study Site — Baltimore, Maryland, United States
Galderma Study Site — Chestnut Hill, Massachusetts, United States
Galderma Study Site — Mount Kisco, New York, United States
Galderma Study Site — New York, New York, United States
Galderma Study Site — New York, New York, United States
Galderma study site — Charleston, South Carolina, United States
Galderma study site — Bellaire, Texas, United States
Galderma Study site — Dallas, Texas, United States
Galderma Study Site — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.